All the subjects were told at the beginning of the trial that the pills they were given contained no active pharmacological ingredients, yet a notable placebo effect was still detected.

Catarina Craveiro, a biomedical research technician from Lisbon, had been hobbled by lower back pain from scoliosis since childhood, unable to do much physically and dependent on ibuprofen for relief.

The primary value of placebo controls in clinical trials is the minimization of bias.

Only 1 in 10 nonsurgical treatments for low back pain are more effective placebo, a review of 56 different treatments and ...

Craveiro from Lisbon had scoliosis since childhood, but now, she is not just free from any pain, but has become a competitive ...

That’s the potential promise of a new study on a drug made by Japanese pharmaceutical company Shionogi. At a scientific ...

Discover recent clinical trial failures in depression and explore potential pathways for advancing antidepressant drug ...

Microdosing, or low-dose treatment of psychedelics such as lysergic acid diethylamide (LSD), has gained popularity in recent ...

While, on average, it takes eight years to be diagnosed with endometriosis, there are, thankfully, new breakthroughs in ...

The Food and Drug Administration (FDA) recently approved a new, non-opioid (non-narcotic) prescription pill, suzetrigine (SUE ...